Clinical Report: Impact of Comprehensive Lymphadenectomy on Survival Outcomes
Overview
Revise to include source attribution for the statement on survival benefit variation.
Background
Remove unsupported claims regarding the necessity of understanding lymphadenectomy's impact.
Data Highlights
Comparison
Hazard Ratio (HR)
95% Confidence Interval (CI)
PPaLND vs No Lymphadenectomy
0.61
0.49–0.75
PPaLND vs PLND
0.60
0.44–0.81
Intermediate-to-High Risk Subgroup
0.62
0.31–1.24
Intermediate Risk Group
0.65
0.01–44.47
High Risk Group
0.43
0.05–4.04
Key Findings
Remove conclusions about survival benefits that are not directly supported by the source.
Clinical Implications
The findings suggest that while PPaLND may improve overall survival for endometrial cancer patients, its benefits are not uniformly applicable across all risk groups. Clinicians should weigh the potential survival benefits against the risks of surgical complications when making treatment decisions.
Conclusion
Revise to reflect only findings without unsupported claims about further trials.
